The North American Knowledge-based/Evidence-based Clinical Decision Support System (CDSS) market is expected to reach around $283.3 million by 2018 - MicroMarket Monitor

Share Article

The North American Knowledge-Based/Evidence-Based Clinical Decision Support System (CDSS) market is highly driven by favorable government initiatives to better streamline the healthcare solutions and reduce the healthcare costs

MicroMarket Monitor

MicroMarket Monitor

Key Players in the North American Knowledge-based/Evidence-based Clinical Decision Support System (CDSS) market are Cerner Corporation, Athenahealth, Inc., McKesson Corporation, and Zynx Health Incorporated.

The North American Knowledge-based/Evidence-based Clinical Decision Support System (CDSS) market report defines and segments the market in North America with analysis and forecast of revenue. The knowledge-based/evidence-based CDSS market in North America is expected to reach around $283.3 million by 2018, at a developing CAGR of 8.1% from 2013 to 2018.

Browse through the TOC of the North American Knowledge-based/evidence-based clinical decision support system (CDSS) market, to get an idea of the in-depth analysis provided. This also provides a glimpse of the market segmentation, and is supported by various tables and figures.

The knowledge-based/evidence-based CDSS is used to decrease the rate of medication errors, and increase the quality and efficiency of dispensing medication. The hospital information systems are installed on a large-scale in North America, and they include Electronic Health Records (EHR), Computerized Physician Order Entry (CPOE) Systems, Laboratory Information Systems (LIS), Patient Information Sheets (PIS), and diagnostic imaging solutions. These solutions are specifically used to collect, store, and retrieve historical and current data, thereby creating the need for solutions that can analyze large amounts of information and recommend better solutions to patients. To meet this need, the clinical decision support system (CDSS) was introduced as an efficient solution that can offer personalized medicine at the point of care.

Speak to Analyst @

The North American knowledge-based/evidence-based CDSS market is expected to grow, as healthcare expenditures are reducing with the decision support system. Reducing the cost of healthcare is one of the major challenges in the U.S.; however, with the use of decision support systems, the market is expected to accelerate in future. Healthcare accounted for 17.6% of the GDP in 2010, and this figure is estimated to reach 26% by 2035 (highest across the globe). The growing healthcare costs have pressurized the healthcare industry to provide optimum solutions. Therefore, the rate of adoption of healthcare IT solutions, mainly, clinical informatics solutions such as EHR, and knowledge-based/evidence-based CDSS has increased. Besides, the growing need to integrate healthcare systems will also drive the market. The system integration is an expensive process; however, the return on investments is high. The benefits associated with knowledge-based/evidence-based CDSS are better workflow, elimination of the maintenance cost for the software interfaces, quick retrieval of clinical data, and quick feedback to clinicians.

Early buyers will receive 10% customization on this report.

Favorable support is extended by the government by setting up the Agency for Healthcare Research and Quality (AHRQ), with an objective to provide support for developing, implementing, and evaluating the use of health information technology to improve the healthcare decision making process, to reduce medical errors, and to support the growth of this market.
The key players offering evidence-based support are Zynx Health (Los Angeles), Wolters Kluwer (Netherlands), and Thomson Reuters (U.S.)

This market is segmented and forecast on the basis of components and deployments of knowledge-based/evidence-based CDSS market in the North American region. On the basis of products the market is divided as integrated and standalone knowledge-based/evidence-based CDSS market. The components comprise hardware, software, and services, and the deployments are on-premise, cloud-based, and web-based. The market is further segmented and forecast on the basis of major countries such as U.S., Canada, and Mexico. The market is also segmented and analyzed further on the basis of the major application and end-users.

This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market including major companies of the market.

Related Reports :

European Knowledge-based/Evidence based Clinical decision support systems (CDSS) Market

The European knowledge-based CDSS market was valued at $36 million in 2012, and expected to reach $56 million by 2018, at a CAGR of 7.3%.
The report ‘European Knowledge-based CDSS Market forecast, 2012-2020’ analyzes the market by sub-segments integrated knowledge-based CDSS and standalone knowledge-based CDSS. Integrated CDSS accounts for about 70% of the total market. The European knowledge-based CDSS market can also be segmented based upon components into hardware, software, and services.

Asian Knowledge-based/Evidence based Clinical decision support systems (CDSS) Market
The Asian market accounts for 7% of the total market. Japan accounts for 35% of the total Asian knowledge-based CDSS market, followed by China at 30%.
The major driver for the Asian knowledge-based CDSS market includes the increasing demand for analytical IT solutions that help in point-of-care decision making. The implementation of such solutions has resulted into reduction of cost and improvement in the quality of care provided. Other factors responsible for the growth of the market are the increasing government initiatives and introduction of various incentive plans for healthcare providers.
About MicroMarket Monitor :

MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.

Mr. Chandrasekhar K.
5601 Bridge Street
Suite 300
Fort Worth, TX 76112
Tel: +1-888-502-0539
Email: sales(at)micromarketmonitor(dot)com
Connect with us on LinkedIn at

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mr. Chandrasekhar K.
Follow >
Micro Market Monitor
Like >
Visit website